Method of quantifying the surfactant of a protein preparation

Details for Australian Patent Application No. 2004236021 (hide)

Owner Delta Biotechnology Limited

Inventors Cameron, Jason; Morton, Philip Harvey

Agent Davies Collison Cave

Pub. Number AU-A-2004236021

PCT Pub. Number WO2004/099234

Priority 0310347.0 07.05.03 GB

Filing date 7 May 2004

Wipo publication date 18 November 2004

International Classifications

G01N 031/22 Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroups - using chemical indicators

C11D 001/00 Surface-active non-soap detergents

C07K 001/30 General processes for the preparation of peptides

G01N 021/78 Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/099234 Priority application(s): WO2004/099234

21 December 2006 Change of Name(s) of Applicant(s), Section 104

  Delta Biotechnology Limited The name of the applicant has been changed to Novozymes Delta Limited

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004236022-Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-di benz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof

2004236014-Substituted-1-phthalazinamines as VR1 antagonists